Funding Announcement: Drs. Andreas Vogt and Mark Schurdak have received SBIR funding in collaboration with Qrono, Inc., a Pittsburgh-based immunotherapy company, for the project: Screening for Tolerogenic Adjuvants to Enhance Antigen Specific Immunotherapy for Celiac Disease.